United Therapeutics Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | Outperform |
9
|
$149.12 | $174.55 | 14.00% | 3 | $356.43B |
| PFE | Pfizer | Outperform |
2
|
$26.26 | $32.87 | 16.15% | 6 | $147.23B |
| AMGN | Amgen | Outperform |
4
|
$271.91 | $303.65 | 16.67% | 8 | $144.25B |
| VRTX | Vertex Pharmaceuticals Inc | Outperform |
12
|
$399.92 | $457.59 | 12.52% | 11 | $101.91B |
| REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$900.16 | $961.26 | 16.65% | 8 | $96.37B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$66.95 | $87.82 | 19.49% | 14 | $83.25B |
| GSK | GSK | Outperform |
12
|
£16.40 | £17.30 | 18.90% | 12 | £65.34B |
| BIIB | Biogen | Outperform |
10
|
$194.11 | $299.62 | 50.43% | 13 | $28.26B |
| BAYN | Bayer | Hold |
5
|
27.32€ | 45.15€ | 17.13% | 4 | 25.86€B |
| CE | Celanese | Hold |
13
|
$154.94 | $148.23 | 3.27% | 18 | $17.23B |
| VTRS | Viatris Inc | Hold |
8
|
$11.25 | $11.73 | 6.67% | 5 | $13.36B |
| LQDA | Liquidia | Outperform |
6
|
$13.18 | $19.71 | 112.44% | 2 | $1.12B |